Aptagen, LLC
E22P-AbD43 (ID# 9547)

RNA
E22P–Ab42
Small Organic
50 ± 5 nM (reported value)
77.8°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-rGprGprGprAprCprGprAprAprGprAprCprCprAprAprCprUprGprAprAprCprUprUprUprGprUprGprGprUprGprGprCprGprGprCprUprAprCprUprCprGprUprGprUprUprCprUprUprUprUprGprAprCprUprUprUprGprUprCprCprGprUprGprCprUprGprCprCprAprCprCprUprUprAprCprUprUprCp-3'

77
23318.6 g/mole
667500 L/(mole·cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Murakami K, Obata Y, Sekikawa A, Ueda H, Izuo N, Awano T, Takabe K, Shimizu T, Irie K. An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease. J Biol Chem. 2020 Apr 10;295(15):4870-4880. doi: 10.1074/jbc.RA119.010955.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.